RxDoctor Payments Data

Jennifer Driver, MD

Family Medicine · New Orleans, LANPI 1588076608

Payments from drug & device makers

$3,859in general payments, 2019–2025

Across 42 payments — averaging $91.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$3K
  • AbbVie$478
  • Lilly USA, LLC$107
  • Teva Pharmaceuticals USA, Inc.$43
  • Pfizer$36
  • Mayne Pharma Commercial LLC$22
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$755100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,859 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$23,538
Medicare patients
110
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide100$138,921
OzempicSemaglutide71$74,237
JardianceEmpagliflozin68$73,668
EliquisApixaban45$38,878
ProliaDenosumab21$36,436
Nurtec OdtRimegepant Sulfate11$19,569
WegovySemaglutide13$17,951
SynthroidLevothyroxine Sodium52$6,008
Atorvastatin Calcium335$3,352
Levothyroxine Sodium287$2,319
Estradiol32$2,123
LantusInsulin Glargine,hum.Rec.Anlog20$1,768
Valsartan49$1,575
Losartan Potassium167$1,346
Gabapentin128$1,335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$107$138,921100 claims
Boehringer IngelheimJardiance$19$73,66868 claims
PfizerEliquis, Nurtec Odt$36$58,44756 claims
AbbVieSynthroid$478$6,00852 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →